Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report.

Clinical colorectal cancer - 1 Jun 2021

McGillivray Erin, Farma Jeffrey, Savage Michelle, Hall Michael J, Luo Biao, Jain Rishi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ataxia Telangiectasia Mutated Proteins
Share to Camptothecin
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorouracil

Share to Leucovorin

Share to Neoadjuvant Therapy

Share to Organoplatinum Compounds

Share to Panitumumab

Source

Identifiers

PMID: 33121919
DOI: 10.1016/j.clcc.2020.09.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report.PMID 33121919Read ↗

Response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600E MT colon cancer patients with acquired C-MET amplification and TPM4- ALK fusion: case report and review of literatureSemantic proximity Read ↗

ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.Semantic proximity Read ↗

A case report of pathologically complete response of a huge rectal cancer after systemic chemotherapy with mFOLFOX6.Semantic proximity Read ↗

Prognostic impact of ATM mutations in patients with metastatic colorectal cancerSemantic proximity Read ↗

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer.Semantic proximity Read ↗

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.Semantic proximity Read ↗

Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.Semantic proximity Read ↗

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.